JavaScript is disabled. Please enable to continue!

Mobile search icon
More Resources >> Our People >> Andrzej Benkowski

Andrzej Benkowski

Sidebar Image
Andrzej Benkowski

Andrzej Benkowski

Technical Manager, Probiotics & Dietary Supplements

As the Technical Manager at Eurofins Center of Excellence for Probiotics, Andrzej Benkowski brings over 18 years of expertise in biotics quality management, testing, and technology. With a strong technical background in food microbiology, Andrzej specializes in contract R&D, method development, and pioneering technologies for probiotic evaluation.

Since 2019, Andrzej has chaired the International Probiotic Association (IPA) Technical Committee and has been a member of the IPA Board of Directors since early 2024. He also contributes to the IPA Postbiotics Committee and has served as the IPA expert liaison with the International Organization for Standardization (ISO) TC34/SC9 Working Group 11 since 2022, co-convening their Enumeration Subgroup.

Andrzej is dedicated to advancing the biotics industry by setting rigorous standards and driving innovation with a focus on quality.

Outside of his professional and scientific achievements, Andrzej is a member of the Eurofins Madison Site Employee Engagement Team and manages the Community Supported Agriculture (CSA) Program for the site. A founding member of the funk band Steez, he also plays saxophone, synthesizers, and vocals. Andrzej enjoys the outdoors, spending time with his family, and pretending to be a coffee aficionado. Additionally, he has a passion for collecting sneakers and fitted hats.

 

Below are resources from Andrzej:



Validation of aseptic fillers intended for the production of low-acid, shelf-stable products is a core requirement of the FDA’s low-acid canned food (LACF) regulations (21CFR113 and 108.35). Microbiological challenges of the aseptic zone and packaging material sterilization cycles are important components of the validation process. These challenges are often conducted at the production site using non-pathogenic surrogate organisms that mimic the resistance of the pertinent target pathogen. This presentation will provide a brief history of the use of such surrogates for the validation of low-acid aseptic fillers along with the approach we have used to qualify the surrogates as adequate for the intended technology.”


Formulating a new product can be exciting! But sometimes we are not sure of the effect this can have on growth of spoilage organisms during shelf life or risk of pathogenic bacteria. Martha Kimber from our Advance Microbiology Lab in Fresno, CA discusses this topic in this short video. Eurofins publishes our Ask an Expert Series weekly on our social media platforms.


<< < 1 2 > >>

https://www.eurofinsus.com/food-testing